首页 | 本学科首页   官方微博 | 高级检索  
检索        


PEPDar: A randomized prospective noninferiority study of ritonavir‐boosted darunavir for HIV post‐exposure prophylaxis
Authors:G Fätkenheuer  H Jessen  A Stoehr  N Jung  AB Jessen  T Kümmerle  M Berger  JR Bogner  CD Spinner  C Stephan  O Degen  R Vogelmann  P Spornraft‐Ragaller  E Schnaitmann  B Jensen  A Ulmer  JM Kittner  G Härter  P Malfertheiner  J Rockstroh  G Knecht  S Scholten  T Harrer  WV Kern  B Salzberger  D Schürmann  B Ranneberg
Institution:1. Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany;2. German Centre for Infection Research, partner site Bonn‐Cologne, Cologne, Germany;3. Praxis Jessen2 + Kollegen, Berlin, Germany;4. ifi ‐ Institute for Interdisciplinary Medicine, Study Centre St. Georg, Hamburg, Germany;5. Immunology Outpatient Clinic, Vivantes Auguste Viktoria Hospital, Berlin, Germany;6. Section Infectcious Diseases, Med IV, University Hospital of Munich, Munich, Germany;7. Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany;8. Department of Medicine, Center for Internal Medicine, J. W. Goethe‐University Frankfurt, Frankfurt am Main, Germany;9. Outpatient Infectious Diseases Unit, University Center Hamburg Eppendorf, Hamburg, Germany;10. Department of Internal Medicine, Medical Clinic II, Ruprecht‐Karls‐University Heidelberg, Mannheim, Germany;11. University Hospital Karl Gustav Carus, Dresden, Germany;12. Infectomed, Stuttgart, Germany;13. Department of Gastroenterology, Hepatology and Infectiology, University Hospital Düsseldorf, Düsseldorf, Germany;14. Group Practice Ulmer/Frietsch/Müller/Roll, Stuttgart, Germany;15. Medical Clinic and Outpatient Clinic I, University Hospital Mainz, Mainz, Germany;16. Clinic for Internal Medizin III, Ulm University Medical Center, Ulm, Germany;17. Clinic for Gastroenterology, Hepatology and Infectiology, University Hospital Magdeburg, Magdeburg, Germany;18. Internal Medicine I, Gastroenterology, Infectious Diseases, University Hospital Bonn, Bonn, Germany;19. Internal Medicine Specialist Center Stresemannallee, Frankfurt am Main, Germany;20. Practice Hohenstaufenring, Cologne, Germany;21. Department of Medicine 3, University Medicine Erlangen, Erlangen, Germany;22. Division of Infectious Diseases, University Hospital, Freiburg, Germany;23. Department Internal Medicine I, University Regensburg, Regensburg, Germany;24. Division of Infectiology and Pneumonology, Medical Department, Charité‐University Medicine Berlin, Berlin, Germany;25. Janssen‐Cilag, Neuss, Germany
Abstract:
Keywords:darunavir  lopinavir  occupational exposure  post‐exposure prophylaxis  sexual exposure
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号